Single-agent docetaxel (TXT) as first-line treatment in metastatic breast cancer (MBC)

被引：0
|
作者：
Guarneri, D. [1 ]
Ratti, R. [1 ]
Venturino, A. [1 ]
Addamo, G. [1 ]
Coccorullo, Z. [1 ]
Colloca, G. [1 ]
Campora, E. [1 ]
机构：
[1] Hosp Sanremo, San Remo, IM, Italy
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2007年 / 25卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
11515
引用
收藏
页数：2
相关论文
共 50 条
  • [31] TREATMENT OF METASTATIC BREAST CANCER (MBC) WITH VONORELBINE AND DOCETAXEL
    Savio, Giuseppina
    Leonardi, Vita
    Laudani, Agata
    Pepe, Alessio
    Calabria, Caterina
    Scianna, Caterina
    Palmisano, Valentina
    Agostara, Biagio
    ANNALS OF ONCOLOGY, 2004, 15 : 20 - 21
  • [32] Phase II study of single-agent pegylated liposomal doxorubicin HCl (PLD) in metastatic breast cancer after first-line treatment failure
    Mlineritsch, B
    Mayer, P
    Rass, C
    Reiter, E
    Russ, G
    Vesenmayer, G
    Oberaigner, W
    Hausmaninger, H
    ONKOLOGIE, 2004, 27 (05): : 441 - 446
  • [33] Treatment of metastatic breast cancer (MBC) with Vinorelbine and Docetaxel
    Savio, Giuseppina
    Leonardi, Vita
    Alu, Massimiliano
    Laudani, Agata
    Calabria, Caterina
    Scianna, Caterina
    Agostara, Biagio
    Ascoli, Maurizio
    ANNALS OF ONCOLOGY, 2004, 15 : 48 - 48
  • [34] Docetaxel as Single-Agent Treatment in Elderly Patients with Advanced Breast Cancer
    I. Lorenzo
    M. Constenla
    P. Palacios
    F. R. García-Arroyo
    I. Fernández
    B. Campos
    L. Salgado
    N. Carrete
    Clinical Drug Investigation, 2005, 25 : 249 - 256
  • [35] Docetaxel as single-agent treatment in elderly patients with advanced breast cancer
    Lorenzo, I
    Constenla, M
    Palacios, P
    García-Arroyo, FR
    Fernández, I
    Campos, B
    Salgado, L
    Carrete, N
    CLINICAL DRUG INVESTIGATION, 2005, 25 (04) : 249 - 256
  • [36] Single-agent capecitabin maintenance therapy after induction of XELOX (or FOLFOX) in first-line treatment of metastatic colorectal cancer
    Xu, R.
    Yuhong, L.
    Huiyan, L.
    Wei, W.
    Zhiqiang, W.
    Xia, Y.
    Dong, M.
    Hua, W. Feng
    Dongsheng, Z.
    Daren, L.
    Chen, L. Yin
    Jun, J.
    Hua, H. Xiao
    Wen, P. Jie
    EUROPEAN JOURNAL OF CANCER, 2015, 51 : S373 - S374
  • [37] Combination of docetaxel and doxorubicin as first-line chemotherapy in metastatic breast cancer
    Baltali, E
    Özisik, Y
    Güler, N
    Firat, D
    Altundag, K
    TUMORI, 2001, 87 (01) : 18 - 19
  • [38] WEEKLY EPIRUBICIN AND DOCETAXEL AS FIRST-LINE CHEMOTHERAPY IN METASTATIC BREAST CANCER
    D'Ottavio, A.
    Vaccaro, A.
    Belli, F.
    Nunziata, C.
    Meliffi, L.
    Moscetti, L.
    Barduagni, M.
    Sperduti, I.
    Gamucci, T.
    ANNALS OF ONCOLOGY, 2004, 15 : 19 - 19
  • [39] Trastuzumab combined with doublet or single-agent chemotherapy as first-line therapy for HER2-positive metastatic breast cancer
    Yu, Y. F.
    Wang, Y.
    Fu, T. P.
    Chen, K.
    Liu, J. Q.
    Yao, H. R.
    BREAST CANCER RESEARCH AND TREATMENT, 2018, 168 (02) : 337 - 348
  • [40] Trastuzumab combined with doublet or single-agent chemotherapy as first-line therapy for HER2-positive metastatic breast cancer
    Y. F. Yu
    Y. Wang
    T. P. Fu
    K. Chen
    J. Q. Liu
    H. R. Yao
    Breast Cancer Research and Treatment, 2018, 168 : 337 - 348
12345